Neoplasm Metastasis  >>  Beleodaq (belinostat)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Beleodaq (belinostat) / Aurobindo, Assertio
NCT00357162: Belinostat in Treating Patients With Myelodysplastic Syndromes

Checkmark P2 data
May 2011 - May 2011: P2 data
Completed
2
21
US
belinostat, PXD101
National Cancer Institute (NCI)
de Novo Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes, Secondary Myelodysplastic Syndromes
12/10
12/10
NCT00873119 / 2008-005865-67: Belinostat, Carboplatin and Paclitaxel (BelCaP) Compared to Carboplatin and Paclitaxel in Patients With Cancer of Unknown Primary

Completed
2
89
US, Europe
belinostat, carboplatin, paclitaxel, PXD101, Belinostat, Carboplatin, Paclitaxel, Taxol, carboplatin, paclitaxel
Onxeo, Spectrum Pharmaceuticals, Inc
Carcinoma of Unknown Primary
12/12
12/12

Download Options